Bintrafusp-alfaSpringer Science and Business Media LLCSpringer Science and Business Media LLC2021DOI 10.1007/s40278-021-98214-9
Bintrafusp-alfa/triamcinoloneSpringer Science and Business Media LLCSpringer Science and Business Media LLC2021DOI 10.1007/s40278-021-98215-9
Erste Daten zu Bintrafusp alfaRedaktion FacharztmagazineSpringer-Verlag2020DOI 10.1007/s15004-020-8282-2
Neoadjuvante Therapie Mit Bintrafusp Alfa Beim Resektablen Cholangiokarzinom; Neoadjuvant Bintrafusp Alfa in Patients with Resectable Biliary Tract Cancer;Oliver WaidmannSpringer-Verlag2020DOI 10.1007/s12312-020-00828-6
Population Pharmacokinetic Analysis of Bintrafusp Alfa in Different Cancer TypesWilkins, Justin J.Springer Healthcare Communications2019DOI 10.1007/s12325-019-01018-0
Bintrafusp-α/eculizumab: Acute kidney injury and thrombotic microangiopathy: case reportReactions WeeklyReactions Weekly2021DOI 10.1007/s40278-021-88713-3
NHS-IL12 and Bintrafusp Alfa Combination Therapy Enhances Antitumor Activity in Preclinical Cancer ModelsChunxiao XuElsevier BV2021DOI 10.1016/j.tranon.2021.101322
Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responsesLan, YanJournal for ImmunoTherapy of Cancer2022DOI 10.1136/jitc-2021-004122
Immune Correlates of Clinical Parameters in Patients with HPV-associated Malignancies Treated with Bintrafusp AlfaYo-Ting TsaiBMJ Publishing Group2022DOI 10.1136/jitc-2022-004601
Bullous Pemphigoid Secondary to Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-beta and PD-L1Wiggins, Claire J.JAAD Case Reports2021DOI 10.1016/j.jdcr.2021.04.027
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfaIngrid Julienne Georgette BurvenichSpringer Science and Business Media LLC2021DOI 10.1007/s00259-021-05251-0
375 Expansion of HPV-16 Specific T Cells in Patients with HPV-related Cancers Treated with Bintrafusp AlfaToney, NicoleBMJ2020DOI 10.1136/jitc-2020-sitc2020.0375